Prognostic factors for actual long-term survival in the era of multidisciplinary treatment for pancreatic ductal adenocarcinoma
出版年份 2018 全文链接
标题
Prognostic factors for actual long-term survival in the era of multidisciplinary treatment for pancreatic ductal adenocarcinoma
作者
关键词
Pancreatic cancer, Multidisciplinary treatment, Actual long-term survival, Prognostic factor
出版物
LANGENBECKS ARCHIVES OF SURGERY
Volume 403, Issue 6, Pages 693-700
出版商
Springer Nature America, Inc
发表日期
2018-09-16
DOI
10.1007/s00423-018-1709-7
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Actual long-term outcome of T1 and T2 pancreatic ductal adenocarcinoma after surgical resection
- (2017) San Hyup Han et al. International Journal of Surgery
- Preoperative Gemcitabine-based Chemoradiation Therapy for Borderline Resectable Pancreatic Cancer
- (2016) Hidenori Takahashi et al. ANNALS OF SURGERY
- Adjuvant Hepatic Arterial Infusion Chemotherapy After Resection for Pancreatic Cancer Using Coaxial Catheter-Port System Compared with Conventional System
- (2016) Aya Hashimoto et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Preoperative FOLFIRINOX for borderline resectable pancreatic cancer: Is radiation necessary in the modern era of chemotherapy?
- (2016) Sunhee S. Kim et al. JOURNAL OF SURGICAL ONCOLOGY
- Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)
- (2016) Katsuhiko Uesaka et al. LANCET
- Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
- (2016) Andrea Wang-Gillam et al. LANCET
- Isolated pulmonary metastases define a favorable subgroup in metastatic pancreatic cancer
- (2016) Stephan Kruger et al. PANCREATOLOGY
- Outcomes of a Clinical Pathway for Borderline Resectable Pancreatic Cancer
- (2015) Omar M. Rashid et al. ANNALS OF SURGICAL ONCOLOGY
- Survival Impact of Pulmonary Metastasis as Recurrence of Pancreatic Ductal Adenocarcinoma
- (2015) Kotaro Yamashita et al. DIGESTIVE SURGERY
- Importance of resectability status in neoadjuvant treatment for pancreatic cancer
- (2015) Masayuki Sho et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Optimal indication of neoadjuvant chemoradiotherapy for pancreatic cancer
- (2015) Masayuki Sho et al. LANGENBECKS ARCHIVES OF SURGERY
- Resected pancreatic ductal adenocarcinomas with recurrence limited in lung have a significantly better prognosis than those with other recurrence patterns
- (2015) Tamna Wangjam et al. Oncotarget
- Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinoma
- (2014) Kenjiro Kimura et al. World Journal of Surgical Oncology
- Five-year actual survival after pancreatoduodenectomy for pancreatic head cancer
- (2013) Iraklis Perysinakis et al. ANZ JOURNAL OF SURGERY
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of preoperative therapy on patterns of recurrence in pancreatic cancer
- (2013) Pavlos Papavasiliou et al. HPB
- Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators
- (2012) Matthew H. G. Katz et al. CANCER
- Selective Reoperation for Locally Recurrent or Metastatic Pancreatic Ductal Adenocarcinoma Following Primary Pancreatic Resection
- (2012) Ryan M. Thomas et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Pathological and clinical impact of neoadjuvant chemoradiotherapy using full-dose gemcitabine and concurrent radiation for resectable pancreatic cancer
- (2012) Masayuki Sho et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Pancreatic ductal adenocarcinoma: Long-term survival does not equal cure
- (2012) Cristina R. Ferrone et al. SURGERY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection
- (2010) John P. Neoptolemos et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Novel postoperative adjuvant strategy prevents early hepatic recurrence after resection of pancreatic cancer
- (2010) Masayuki Sho et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Analysis of 5-Year Survivors After a Macroscopic Curative Pancreatectomy for Invasive Ductal Adenocarcinoma
- (2010) Kazuaki Shimada et al. WORLD JOURNAL OF SURGERY
- Long-Term Survival After Pancreatoduodenectomy for Pancreatic Adenocarcinoma
- (2009) Thomas Schnelldorfer et al. ANNALS OF SURGERY
- The Clavien-Dindo Classification of Surgical Complications
- (2009) Pierre A. Clavien et al. ANNALS OF SURGERY
- Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma
- (2009) Matthew H. G. Katz et al. ANNALS OF SURGICAL ONCOLOGY
- A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer
- (2009) H Ueno et al. BRITISH JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started